← All companies

EPRX

Eupraxia Pharmaceuticals Inc.

EPRX Nasdaq Pharmaceutical Preparations EDGAR ↗

$6.51

-0.04 -0.61%

Key statistics

from XBRL data in SEC filings

Market cap

$260M

Revenue (TTM)

$0.00

Net income (TTM)

-$38.6M

EPS (TTM)

$-1.03

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$80.6M

Total assets

$86.2M

Gross margin

—

52-week range

$5.04 – $9.32

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 15, 2026 6-K FORM 6-K Jul 13, 2026 6-K FORM 6-K Jul 7, 2026 6-K FORM 6-K Jun 22, 2026 6-K FORM 6-K May 29, 2026 6-K FORM 6-K May 29, 2026 6-K FORM 6-K May 28, 2026 6-K May 12, 2026 6-K FORM 6-K May 6, 2026 6-K FORM 6-K May 5, 2026 6-K FORM 6-K May 1, 2026 6-K FORM 6-K Apr 22, 2026 6-K FORM 6-K Apr 21, 2026 6-K FORM 6-K Apr 15, 2026 6-K Apr 15, 2026 6-K FORM 6-K Mar 17, 2026 40-F Mar 13, 2026 6-K Mar 6, 2026 6-K FORM 6-K Feb 20, 2026 6-K Feb 20, 2026 6-K FORM 6-K Feb 19, 2026 6-K FORM 6-K Feb 18, 2026 6-K FORM 6-K Jan 8, 2026 6-K FORM 6-K Nov 13, 2025 6-K Nov 4, 2025 6-K FORM 6-K Oct 1, 2025 6-K Sep 29, 2025 6-K FORM 6-K Sep 24, 2025 6-K Sep 23, 2025 6-K FORM 6-K Sep 23, 2025 6-K FORM 6-K Sep 22, 2025 6-K Sep 19, 2025 6-K FORM 6-K Sep 2, 2025 6-K Aug 13, 2025 6-K FORM 6-K Jul 22, 2025 6-K FORM 6-K Jul 8, 2025 6-K FORM 6-K Jun 3, 2025 6-K FORM 6-K Jun 2, 2025 6-K FORM 6-K May 7, 2025 6-K May 6, 2025